12th Annual World ADC London
29th March – 1st April 2022
London

The ADC field is going from strength to strength, further catalysed in 2021 by the approvals of Zynlonta and Tivdak respectively, bringing the total number of commercially available ADCs to 11.

Returning in-person in from 29th March – 1st April, be part of the 12th Annual World ADC London and reconnect with 400+ of your peers at the forefront of ADC drug development.

After in-depth research with key opinion leaders within the ADC field, this is your most extensive programme to-date addressing the most pressing challenges facing ADC developers from discovery through to late phase manufacturing.

Take a look at the brand-new agenda here!

The four-streamed, four-day unrivalled programme with 75+ industry-leading speakers will equip you with the insights and connections to nourish your current pipelines of ADCs, discover the next generation of non-traditional ADCs, and confidently define your manufacturing processes.

Register now and join the likes of the likes of Daiichi Sankyo, AstraZeneca, ADC Therapeutics, Seagen and many more to work collaboratively to overcome the distinct challenges ADC drug development holds and maximise the therapeutic window of ADCs.